Loading chat...
AR SB53
Bill
Status
2/25/2015
Primary Sponsor
Missy Irvin
Click for details
AI Summary
Arkansas SB53 Summary
-
Requires physicians to physically administer mifepristone or other abortion-inducing drugs in the same room where the patient is present, rather than remotely or through alternative means.
-
Mandates follow-up visits 12-18 days after drug administration for physicians to confirm pregnancy termination and assess the patient's medical condition, with documentation of efforts in medical records.
-
Authorizes the Arkansas State Medical Board to revoke the license of any physician found to have violated these requirements.
-
Creates civil causes of action allowing pregnant women, married fathers of the unborn child, and maternal grandparents to sue abortion providers for actual and punitive damages for violations; permits citizens to seek injunctions against repeat violators.
-
Prohibits penalties against the pregnant woman and exempts her from liability for obtaining or possessing abortion-inducing drugs; allows anonymity protections in civil proceedings at the court's discretion.
Legislative Description
To Regulate The Use Of Certain Drugs Used To Induce An Abortion; And To Provide For Disciplinary Proceedings For Abortions Performed In Violation Of This Act.
Last Action
Notification that SB53 is now Act 139
2/25/2015